Metabiologics
Technology
Botulinum neurotoxin is produced by the bacterium Clostridium botulinum. The neurotoxin produces a dose-related weakness of skeletal muscle by impairing the release of acetylcholine at the neuromuscular junction. There are at least seven immunologically distinct forms of botulinum neurotoxin, designated as serotypes A-G. Type A neurotoxin is the most commonly used in human medicine.
Metabiologics was founded in 1999 by scientists from the University of Wisconsin Food Research Institute, who have been conducting botulinum neurotoxin research since the 1980's. Botulinum neurotoxins’ high profile as a food contaminant comes from the neurotoxins’ ability to weaken skeletal muscles to such an extent that it can cause partial paralysis and result in respiratory failure. During the 1990's, notable improvements in the development and manufacturing of research grade botulinum neurotoxin were made, and Metabiologics was born.
Metabiologics is committed to the production of high quality reagent grade products. Researchers and corporate entities are encouraged to contact us regarding potential experimental collaborations.
Contact
Phone
949-269-3260
Info@metabiologics.com
Fax
949-600-5364